SEROXAT

Motion Text

That this House expresses concern at the tragic deaths associated with the anti-depressant drug Seroxat and the news that GlaxoSmithKline suppressed news of two 1998 studies that demonstrated that the drug was no more effective than placebos; notes with alarm the Department of Health's view that Seroxat can make the symptoms of depression more severe and the decision of a court that Seroxat was responsible for a change in the behaviour of a man who took his own life and that of his family; and calls for a full investigation of the conduct of GlaxoSmithKline who appear to have put their private greed before public safety.